Clinical Trial Update: Role of Anti-TREK-1 Autoantibodies in SCVF

View source ↗

Summary

This clinical trial investigates the role of anti-TREK-1 autoantibodies in short-coupled ventricular fibrillation and idiopathic ventricular fibrillation and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Ventricular Fibrillation
• Ventricular Fibrillation

Drugs mentioned

• Anti-TREK-1 autoantibodies

Snippet

Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | Conditions: Short-coupled Ventricular Fibrillation, Idiopathic Ventricular Fibrillation | Status: ENROLLING_BY_INVITATION